BioTime (Israel) Price Prediction and Hype Density Breakdown

BTX -- Israel Stock  

ILS 554.40  11.60  2.05%

We analyze noise-free headlines and recent hype associated with BioTime which may create opportunities for some arbitrage if properly timed. With BioTime hype-based prediction module you can estimate the value of BioTime from the prospective of BioTime response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on BioTime over a specific investment horizon. Check also BioTime Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

BioTime After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

BioTime Estimiated After-Hype Price Volatility

December 9, 2018
Current Value
After-hype Price
Target Odds
BioTime is not too risky asset. Analysis and calculation of next after-hype price of BioTime is based on 2 months time horizon.

BioTime Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.88% 4.29% 7.04%  5.44% 1 Events / Month5 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

BioTime Hype Timeline

BioTime is currently traded for 554.40on Tel Aviv Stock Exchange of Israel. This company has historical hype elasticity of 7.04 and average elasticity to hype of competition of 5.44. BioTime is anticipated to increase in value after the next headline with price going to jump to 561.44. The average volatility of media hype impact on the company stock price is about 53.63%. The price growth on the next news is estimated to be 1.27% where as daily expected return is currently at -0.88%. The volatility of related hype on BioTime is about 69.42% with expected price after next announcement by competition of 559.84. The company reported revenue of 5.23M. Net Loss for the year was (72.97M) with profit before overhead, payroll, taxes, and interest of 3.29M. Assuming 30 trading days horizon, the next anticipated press release will be very soon.
Check also BioTime Basic Forecasting Models to cross-verify your projections.

BioTime Related Hype Analysis

At Risk
Kamada Ltd(3.00) 3 per month 0.00 (0.0074)  2.32 (2.47)  6.96 
RedHill Biopharma Ltd 0.00 7 per month 4.01  0.06  6.86 (6.55)  19.66 
BioTime 8.00 1 per month 0.00 (0.22)  5.65 (9.10)  16.21 
Compugen Ltd 3.00 7 per month 0.00  0.0126  3.52 (4.38)  15.94 
Clal Biotechnology Industries Ltd 4.20 3 per month 0.00  0.0112  2.92 (3.33)  9.16 
Pluristem Therapeutics 0.20 1 per month 0.00 (0.1)  2.42 (2.40)  8.49 
Evogene Ltd 54.30 6 per month 0.00 (0.09)  3.24 (3.08)  10.17 
Protalix BioTherapeutics(1.20) 2 per month 4.71  0.0386  14.13 (10.35)  29.36 
Can Fite BioPharma Ltd(3.70) 4 per month 1.94  0.14  4.04 (3.69)  14.85 
Solegreen Ltd 0.00 1 per month 1.31  0.14  3.32 (2.34)  7.75 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 50 shares
Active few hours ago
Purchased over 90 shares
Active few hours ago
Purchased over 70 shares
Active few hours ago
Purchased over 50 shares
Active few hours ago
Purchased over 500 shares
Active few hours ago
Purchased few shares
Active few hours ago
Check also BioTime Basic Forecasting Models to cross-verify your projections. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.